Atlas Trials

Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19

Clinical trial NCT04607928 · UNKNOWN

Trial details

NCT number
NCT04607928
Sponsor
Institut d'Investigació Biomèdica de Bellvitge
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fibrotic Pulmonary Sequelae Post-COVID19 Infection
Start date
2020-08-01
Primary completion
2022-01-30
Enrollment
148

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.